Encompass Health Co. (NYSE:EHC) Receives Average Rating of “Buy” from Brokerages
Encompass Health Co. (NYSE:EHC – Get Free Report) has been given a consensus rating of “Buy” by the seven analysts that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $77.60.
Several equities research analysts have recently commented on EHC shares. Royal Bank of Canada restated an “outperform” rating and set a $83.00 price target on shares of Encompass Health in a research note on Thursday, September 28th. StockNews.com began coverage on Encompass Health in a report on Thursday, October 5th. They set a “buy” rating on the stock.
Get Our Latest Report on Encompass Health
Encompass Health Price Performance
Shares of NYSE EHC opened at $64.80 on Monday. Encompass Health has a twelve month low of $51.15 and a twelve month high of $72.06. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 1.25. The stock has a 50 day moving average of $64.28 and a two-hundred day moving average of $66.27. The stock has a market cap of $6.50 billion, a P/E ratio of 18.51, a P/E/G ratio of 1.37 and a beta of 0.98.
Encompass Health (NYSE:EHC – Get Free Report) last released its quarterly earnings results on Friday, October 27th. The company reported $0.86 EPS for the quarter, topping the consensus estimate of $0.77 by $0.09. Encompass Health had a return on equity of 18.25% and a net margin of 7.54%. The business had revenue of $1.21 billion during the quarter, compared to analysts’ expectations of $1.19 billion. During the same quarter in the prior year, the business earned $0.67 earnings per share. The company’s quarterly revenue was up 10.8% compared to the same quarter last year. On average, research analysts forecast that Encompass Health will post 3.52 earnings per share for the current year.
Encompass Health Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, January 16th. Shareholders of record on Tuesday, January 2nd will be issued a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.93%. The ex-dividend date is Friday, December 29th. Encompass Health’s dividend payout ratio (DPR) is 17.14%.
Insider Buying and Selling at Encompass Health
In other Encompass Health news, CFO Douglas E. Coltharp sold 11,215 shares of the company’s stock in a transaction on Monday, November 13th. The stock was sold at an average price of $63.39, for a total value of $710,918.85. Following the sale, the chief financial officer now owns 116,293 shares of the company’s stock, valued at $7,371,813.27. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.90% of the stock is owned by corporate insiders.
Institutional Trading of Encompass Health
Large investors have recently bought and sold shares of the company. US Bancorp DE boosted its stake in shares of Encompass Health by 66.4% during the first quarter. US Bancorp DE now owns 9,336 shares of the company’s stock valued at $664,000 after acquiring an additional 3,725 shares during the last quarter. Cambridge Investment Research Advisors Inc. acquired a new stake in shares of Encompass Health during the first quarter valued at $318,000. PNC Financial Services Group Inc. boosted its stake in shares of Encompass Health by 10.5% during the first quarter. PNC Financial Services Group Inc. now owns 8,750 shares of the company’s stock valued at $622,000 after acquiring an additional 834 shares during the last quarter. Bank of Montreal Can boosted its stake in shares of Encompass Health by 1.5% during the first quarter. Bank of Montreal Can now owns 11,340 shares of the company’s stock valued at $806,000 after acquiring an additional 173 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in shares of Encompass Health by 10.5% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 36,463 shares of the company’s stock valued at $2,593,000 after acquiring an additional 3,477 shares during the last quarter. Institutional investors and hedge funds own 92.66% of the company’s stock.
Encompass Health Company Profile (Get Free Report
Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Encompass Health, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Encompass Health wasn’t on the list.
While Encompass Health currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.